--- title: SEC Reviews Accredited Investor Requirements description: gllgl image: https://www.glgpharma.com/hs-fs/file-2452278580-jpg/images/white-hires-resized-600.jpg --- [Back to Blog ](https://www.glgpharma.com/glg-pharma-stat-blog) [ accredited investor ](https://www.glgpharma.com/glg-pharma-stat-blog/topic/accredited-investor) [ angel investor ](https://www.glgpharma.com/glg-pharma-stat-blog/topic/angel-investor) [ angel investors ](https://www.glgpharma.com/glg-pharma-stat-blog/topic/angel-investors) [ accredited investors ](https://www.glgpharma.com/glg-pharma-stat-blog/topic/accredited-investors) [ sec ](https://www.glgpharma.com/glg-pharma-stat-blog/topic/sec) [ jobs act ](https://www.glgpharma.com/glg-pharma-stat-blog/topic/jobs-act) # SEC Reviews Accredited Investor Requirements [ by Richard Gabriel ](https://www.glgpharma.com/glg-pharma-stat-blog/author/richard-gabriel) [Share this blog post on Twitter ](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113915/SEC-Reviews-Accredited-Investor-Requirements) [Share this blog post on Facebook ](http://www.facebook.com/share.php?u=https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113915/SEC-Reviews-Accredited-Investor-Requirements) [Share this blog post on LinkedIn ](http://www.linkedin.com/shareArticle?mini=true&url=https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113915/SEC-Reviews-Accredited-Investor-Requirements) This is a short blog: The current debate at the SEC going on right now (December 17, 2014 and we have 60 days to comment on this as the general public) is about the definition of an accredited investor. There are two interesting presentations and anyone can down load by following the link we provide (click on Mary Jo White's picture). Be your own judge if you think that tightening the restrictions will help or hurt our economy and the entrepreneurs starting new businesses or will it just help widen the income gap between the really rich and the not so really rich? Here are some facts: - There are an estimated 8.5 million accredited investors in the US - 400,000 to 500,000 tops, are active private equity investors in startup companies - Regulation D investment for 2014 will come in at about a total of $980 billion - Venture capital about $30-$50 billion (estimate) - Angel capital about $25-$35 billion (estimate) - Private equity - $350 billion+ (est.) - The rest ($550+ billion) is who knows? - The IPO market will be about $250-$300 billion (est.)  [![SEC, Chairman, Accredited Investor](https://www.glgpharma.com/hs-fs/file-2452278580-jpg/images/white-hires-resized-600.jpg?width=216&height=269&name=white-hires-resized-600.jpg)](http://www.sec.gov/info/smallbus/acsec.shtml)  Ms Mary Jo White SEC Chairperson Just click the image and it will take you to the SEC site where you can download the two presentations. You will see the link on the right hand side under the date: December 17, 2014. If you are a visual person, then you can go to the following two links and if you have Windows Media player, you can actually hear who is saying what in the meeting! [SEC Recorded: Session 1 and 2](http://www.sec.gov/news/otherwebcasts/2014/acsec121714.shtml)     Thanks and good luck listening and reading. For entrepreneur's this is a vital discussion!                           ### Comments ## Related Posts [Read more ](https://www.glgpharma.com/glg-pharma-stat-blog/blog/glg-pharma-at-rare-disease-day-tallahassee-florida?hsLang=en-us) [Rare Diseases](https://www.glgpharma.com/glg-pharma-stat-blog/topic/rare-diseases) ## [GLG Pharma at Rare Disease Day Tallahassee Florida!](https://www.glgpharma.com/glg-pharma-stat-blog/blog/glg-pharma-at-rare-disease-day-tallahassee-florida?hsLang=en-us) FOR IMMEDIATE RELEASE  GLG Pharma is participating along with Rare Disease Advocates Commemorate Worldwide... [ Richard Gabriel ](https://www.glgpharma.com/glg-pharma-stat-blog/author/richard-gabriel) Wed, Feb 18, 2015 @ 04:47 PM [Read more ](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113774/Why-Invest-in-Early-Stage-Drug-Development-for-Rare-Diseases?hsLang=en-us) [STAT3](https://www.glgpharma.com/glg-pharma-stat-blog/topic/stat3) [STAT3 inhibitors](https://www.glgpharma.com/glg-pharma-stat-blog/topic/stat3-inhibitors) [Cancer](https://www.glgpharma.com/glg-pharma-stat-blog/topic/cancer) [Alpha-1](https://www.glgpharma.com/glg-pharma-stat-blog/topic/alpha-1) [Rare Diseases](https://www.glgpharma.com/glg-pharma-stat-blog/topic/rare-diseases) [Alpha-1 Antitry](https://www.glgpharma.com/glg-pharma-stat-blog/topic/alpha-1-antitry) [Rare Disease](https://www.glgpharma.com/glg-pharma-stat-blog/topic/rare-disease) ## [Why Invest in Early Stage Drug Development for Rare Diseases?](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113774/Why-Invest-in-Early-Stage-Drug-Development-for-Rare-Diseases?hsLang=en-us) Ok, so in one of my past lives, as a member of our team at Pharm-eco Laboratories and with an excellent team at... [ Richard Gabriel ](https://www.glgpharma.com/glg-pharma-stat-blog/author/richard-gabriel) Mon, Dec 08, 2014 @ 02:54 PM ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Richard Gabriel", "url" : "https://www.glgpharma.com/glg-pharma-stat-blog/author/richard-gabriel" }, "datePublished" : "2015-01-02T17:33:00.000Z", "headline" : "SEC Reviews Accredited Investor Requirements", "image" : [ "https://www.glgpharma.com/hs-fs/file-2452278580-jpg/images/white-hires-resized-600.jpg" ], "mainEntityOfPage" : { "@id" : "https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113915/SEC-Reviews-Accredited-Investor-Requirements", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://www.glgpharma.com/hubfs/2022%20Images/Logo%20Images/glg_pharma_logo-02-04-182.jpg" }, "name" : "GLG Pharma" } } ```